University Health Network-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University Health Network - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013494
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibility, health records, hospitality services and volunteer resources. The organization conducts research in the fields of neurosciences, cardiology, oncology, transplantation, surgical innovation, genomic medicine, infectious diseases, and rehabilitation medicine. UHN is a network of health care and teaching institutions, namely, Toronto General and Toronto Western Hospitals, the Princess Margaret Cancer Centre, Toronto Rehabilitation Institute and The Michener Institute of Education at UHN. It is a research hospital affiliated to the University of Toronto. UHN is headquartered in Toronto, Ontario, Canada.

University Health Network – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University Health Network, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University Health Network, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University Health Network, Medical Devices Deals, 2011 to YTD 2017 10
University Health Network, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University Health Network, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
DLVR Therapeutics Secures Additional Investment In Seed Financing 12
Partnerships 13
Theralase Technologies Expands its Research Agreement with University Health Network 13
OncoTherics Enters into Agreement with University Health Network 14
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15
Licensing Agreements 16
VistaGen Therapeutics Enters into Licensing Agreement with University Health Network 16
VistaGen Therapeutics Enters Licensing Agreement with University Health Network 17
Sernova Enters into Licensing Agreement with University Health Network 18
Avrobio Enters into Licensing Agreement with University Health Network 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
Stem Cell Therapeutics Enters into Licensing Agreement with University Health Network 21
University Health Network – Key Competitors 22
University Health Network – Key Employees 23
University Health Network – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Government and Public Interest 25
Nov 23, 2017: Innovative Medicines Canada and Astellas Announce Grant to the University Health Network’s Transplant Innovation Fund 25
Nov 15, 2017: Molecular pathway offers treatment targets for pulmonary fibrosis, related conditions 26
Nov 06, 2017: UHN Vision Scientists Discover Potential Neuroprotective Treatment For Glaucoma 28
Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than $10 million in new funding 29
Nov 08, 2016: Blocking the Formation of a Cancer in the Brain 30
Aug 29, 2016: Breast cancer Researchers Look Beyond Genes to Find More Drivers of Disease Development 31
Aug 04, 2016: Research team discovers two biomarkers that contribute to spine osteoarthritis 32
Jul 14, 2016: Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood 33
Jul 14, 2016: Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood for future clinical use 34
Jun 28, 2016: Prostate cancer researchers use liquid biopsy biomarkers to identify aggressive disease before treatment 35
Apr 19, 2016: Breast cancer patients receiving Herceptin treatment should be monitored for heart damage at any age 36
Jan 07, 2016: Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario 37
Product News 38
Feb 06, 2017: Immune therapy scientists discover distinct cells that block cancer-fighting immune cells 38
Other Significant Developments 39
Apr 12, 2017: University Health Network: First-of-its-kind app offers personalized rehab therapy for stroke patients 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
University Health Network, Pharmaceuticals & Healthcare, Key Facts 2
University Health Network, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University Health Network, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University Health Network, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University Health Network, Deals By Therapy Area, 2011 to YTD 2017 9
University Health Network, Medical Devices Deals, 2011 to YTD 2017 10
University Health Network, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
DLVR Therapeutics Secures Additional Investment In Seed Financing 12
Theralase Technologies Expands its Research Agreement with University Health Network 13
OncoTherics Enters into Agreement with University Health Network 14
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 15
VistaGen Therapeutics Enters into Licensing Agreement with University Health Network 16
VistaGen Therapeutics Enters Licensing Agreement with University Health Network 17
Sernova Enters into Licensing Agreement with University Health Network 18
Avrobio Enters into Licensing Agreement with University Health Network 19
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 20
Stem Cell Therapeutics Enters into Licensing Agreement with University Health Network 21
University Health Network, Key Competitors 22
University Health Network, Key Employees 23
University Health Network, Subsidiaries 24

★海外企業調査レポート[University Health Network-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TOKIN Corp:企業の戦略的SWOT分析
    TOKIN Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Aemetis Inc (AMTX):企業の財務・戦略的SWOT分析
    Summary Aemetis Inc (Aemetis) formerly AE Biofuels Inc is a renewable fuels and biochemicals company that produces advanced fuels and chemicals. The company’s products include biochemicals, renewable fuels, ethanol, ethanol co-products, glycerin, biodiesel, and edible oils, among others. It also pro …
  • RLJ Lodging Trust:企業の戦略・SWOT・財務情報
    RLJ Lodging Trust - Strategy, SWOT and Corporate Finance Report Summary RLJ Lodging Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Guitar Center, Inc.:企業の戦略的SWOT分析
    Guitar Center, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Southern Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary Southern Research Institute (Southern Research) is a contract research organization which conducts research in the areas of advanced engineering, preclinical drug development, drug discovery and environmental protection. Its life science services include preclinical drug development, basic r …
  • The Miyazaki Bank Ltd.:企業の戦略・SWOT・財務情報
    The Miyazaki Bank Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Miyazaki Bank Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • US Physical Therapy Inc (USPH):企業の財務・戦略的SWOT分析
    US Physical Therapy Inc (USPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Maintel Holdings Plc (MAI):企業の財務・戦略的SWOT分析
    Summary Maintel Holdings Plc (Maintel) is a telecommunication service provider that supports voice and data equipments. The company provides collaborations, customer experience and optimization, connectivity, security and networking, mobile professional and transformation services and managed servic …
  • Grasim Industries Ltd (GRASIM):企業の財務・戦略的SWOT分析
    Grasim Industries Ltd (GRASIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • BNP Paribas SA:企業の戦略・SWOT・財務情報
    BNP Paribas SA - Strategy, SWOT and Corporate Finance Report Summary BNP Paribas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Polaris Infrastructure Inc (PIF):企業の財務・戦略的SWOT分析
    Summary Polaris Infrastructure Inc (Polaris Infrastructure), formerly Ram Power Corp is a renewable energy company that explores, acquires, operates and develops geothermal energy projects in Latin America. The company owns and operates San Jacinto Tizate Geothermal project, which is located in nort …
  • Disco Corp (6146):企業の財務・戦略的SWOT分析
    Disco Corp (6146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Corning Incorporated (GLW)-医療機器分野:企業M&A・提携分析
    Summary Corning Incorporated (Corning) manufactures and sells ceramics, specialty glasses and related materials. The company’s product portfolio includes glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for tele …
  • Grupo Argos SA:企業の戦略・SWOT・財務分析
    Grupo Argos SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Argos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CG Power and Industrial Solutions Ltd (CGPOWER)-エネルギー分野:企業M&A・提携分析
    Summary CG Power and Industrial Solutions Ltd (CG), formerly Crompton Greaves Limited provides solutions for the management and application of electrical energy. It carries out the design, manufacture and marketing of electrical products and services related to utilities, power generation and indust …
  • BioMark Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMark Diagnostics Inc (BioMark Diagnostics) is an oncology-focused medical equipment company that owns and develops multiple intellectual properties in detection and quantitation of metabolites. The company’s advanced near-to- market diagnostic technologies designed to improve patient outc …
  • The Pep BoysManny, Moe & Jack:企業の戦略・SWOT・財務分析
    The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report Summary The Pep BoysManny, Moe & Jack - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Getlink SE (GET):企業の財務・戦略的SWOT分析
    Getlink SE (GET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Respira Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Respira Therapeutics Inc (Respira) is a pharmaceutical development company that develops dry powder inhaler technologies. The company develops Inhaler technologies to enable targeted lung delivery of drugs to treat pulmonary diseases. It develops products used for the treatment of pulmonary …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆